Effect of graded hypoxia on the induction and function of inducible nitric oxide synthase in rat mesangial cells

Circulation Research
S L ArcherP J Shultz

Abstract

Inducible nitric oxide synthase (iNOS) catalyzes the formation of nitric oxide (NO) from L-arginine and O2. Although some O2 is required for this reaction, it is uncertain whether biologically relevant levels of hypoxia alter this pathway. We examined the effects of graded hypoxia on several steps in the iNOS pathway in lipopolysaccharide (LPS)-stimulated rat glomerular mesangial cells: induction of iNOS mRNA, NO synthesis, NO oxidation to nitrite (NO2-) and nitrate (NO3-), and accumulation of cGMP. Cultured cells were incubated for 24 hours in airtight flasks containing O2 (21%, 10%, 2.5%, and 0%), CO2 (5%), and N2 (balance), resulting in media PO2 levels of 140 +/- 3, 85 +/- 1, 46 +/- 3 (moderate hypoxia), and 32 +/- 5 (severe hypoxia) mm Hg, respectively. During normoxia (PO2, 85 to 140 mm Hg) LPS increased iNOS mRNA with associated increases in NO synthesis, NO2- and NO3- accumulation, and intracellular cGMP levels. In the absence of LPS, there was minimal NO synthesis and no detectable iNOS mRNA. Even during severe hypoxia, LPS elevated NO2- and NO3- relative to levels in unstimulated cells (P < .05), although to a lesser extent than during normoxia (P < .05). The induction of iNOS mRNA by LPS was preserved in hypoxia, and...Continue Reading

References

Nov 1, 1992·The Journal of Clinical Investigation·P J Shultz, L Raij
Nov 1, 1992·Chemical Research in Toxicology·W H KoppenolJ S Beckman
Apr 1, 1992·The Journal of Clinical Investigation·L De NicolaF B Gabbai
May 30, 1991·The New England Journal of Medicine·A T Dinh-XuanJ Wallwork
Nov 15, 1989·Biochemical and Biophysical Research Communications·S L ArcherE K Weir
Dec 1, 1989·Clinical Science·J B WarrenP J Barnes
Aug 1, 1987·Journal of Applied Physiology·B M GrovesC S Houston
Feb 1, 1994·Journal of Applied Physiology·T C IsaacsonS L Archer
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·D KunzJ Pfeilschifter
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·S L ArcherE K Weir
Sep 1, 1994·Kidney International·P J ShultzM E Rosenberg
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D A GellerT R Billiar
Feb 1, 1993·The Journal of Clinical Investigation·P J Shultz, J P Tolins
Feb 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T M Lincoln, T L Cornwell
Feb 26, 1993·Biochemical and Biophysical Research Communications·Y NunokawaS Tanaka
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D A GellerT R Billiar
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroR E Byrns
Jul 1, 1993·The American Journal of Physiology·B E RobertsonM T Nelson
Feb 1, 1993·Journal of the American Society of Nephrology : JASN·L Raij, P J Shultz
Feb 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S Archer
Jan 1, 1993·Journal of Applied Physiology·R D Russ, B R Walker

❮ Previous
Next ❯

Citations

May 1, 1997·Disease-a-month : DM·R G KilbournC Szabó
Apr 27, 2000·Journal of Hepatology·C VargiuS Colombatto
Dec 31, 1996·Brain Research. Molecular Brain Research·N R PrabhakarR N Kalaria
Jun 27, 2003·Nitric Oxide : Biology and Chemistry·Susana Castro-BlancoJosé Rodrigo
Sep 6, 2000·The Biochemical Journal·C C McCormickM Calero
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·Y Z GuC A Bradfield
Dec 26, 2001·American Journal of Respiratory Cell and Molecular Biology·Bruce R Pitt, Claudette M St Croix
Apr 25, 2003·Journal of Pharmaceutical Sciences·Micheal S Guirguis, Fakhreddin Jamali
Oct 1, 2011·Free Radical Biology & Medicine·Mary A RobinsonCynthia M Otto
Jul 18, 2015·International Immunopharmacology·K P MishraShashi Bala Singh
Feb 7, 2004·Cell Transplantation·M de GrootR van Schilfgaarde
Feb 23, 1999·Clinical and Experimental Pharmacology & Physiology·D V Faller
Jan 19, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Q ShiK Xie
Feb 15, 2008·American Journal of Physiology. Cell Physiology·Mary A RobinsonCynthia M Otto
Feb 24, 2001·American Journal of Physiology. Cell Physiology·C M Otto, J E Baumgardner
May 13, 2003·Scandinavian Journal of Gastroenterology·C von BothmerL Fändriks
Jan 14, 1999·The American Journal of Physiology·A KumarJ E Parrillo
Jan 25, 2000·American Journal of Physiology. Endocrinology and Metabolism·M B Ganz, A Seftel
Apr 13, 1999·The American Journal of Physiology·K SatoI F McMurtry
Nov 1, 2003·Cell Transplantation·M de GrootR Van Schilfgaarde
Sep 12, 2003·Experimental Biology and Medicine·Alfredo GrilliMario Felaco
Mar 15, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Karen S Mark, Thomas P Davis
Feb 19, 2000·Biochemical and Biophysical Research Communications·Y HongN Yamada
Feb 9, 2000·Journal of the American Society of Nephrology : JASN·Masao KakokiMasao Omata

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.